Sources: China to approve Qualcomm-NXP deal in next few days, but with conditions, as regulators fear merged company's dominance in areas like mobile payments
Context & Ripple Effects
Qualcomm's $47B bid for NXP has been cleared everywhere except Beijing: the EU signed off in January after the companies addressed competition concerns, and South Korea followed days later. Then the review stalled — by April, China was delaying both Qualcomm-NXP and Bain's Toshiba chip-unit buyout amid the tariff fight with Washington, raising fears both deals would die.
This report says the logjam is breaking: approval within days, but with conditions, driven by regulator concern over a merged company's dominance in areas like mobile payments. Whether those conditions actually materialize stayed contested — weeks later, Reuters reported sources close to the deal were unaware of any Chinese approval, contradicting other outlets.
First-order effects
- Qualcomm and NXP get the last regulatory green light they need to close the acquisition — but only under China-imposed conditions aimed at limiting the combined company's power in mobile payments and adjacent markets.
- The companies' remedy playbook expands again: after concessions cleared the EU and South Korean reviews, Beijing extracts its own set of behavioral commitments as the price of approval.
Second-order effects
- Bain's stalled acquisition of Toshiba's chip unit, stuck in the same Chinese review queue during the tariff standoff, now faces pressure to offer comparable concessions to win its own clearance.
- Other global chipmakers planning consolidation must price Chinese regulatory sign-off — and its timing risk tied to US-China trade friction — into deal timelines and valuations.
Third-order effects
- Merger review hardens into a lever of trade statecraft: when one jurisdiction can hold the final approval hostage during a tariff dispute, antitrust conditions stop being purely competition policy and become negotiating currency between Washington and Beijing.
- If conditional approvals become the norm for cross-border semiconductor deals, deal structures shift toward pre-negotiated conduct commitments and divestiture packages designed for multiple regulators up front.
The trend: Cross-border semiconductor M&A is being pulled into the US-China trade conflict, with China's final-say merger approvals doubling as geopolitical leverage.